Maryland Oncology Hematology, P.A.

Clinical research site in Bethesda, Maryland · 6420 ROCKLEDGE DR STE 4200, BETHESDA, MD 20817-7847 · (301) 929-0765

Part of Maryland Oncology Hematology

As of July 2026, 5 paid clinical trials are recruiting at Maryland Oncology Hematology, P.A. in Bethesda, Maryland. Active studies at this site cover conditions such as Advanced Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung and Carcinoma, Non-Small-Cell Lung (NSCLC). Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at Maryland Oncology Hematology, P.A. (5)

Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer

for Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction , or Esophageal Adenocarcinoma

61 locations incl. Los Angeles

Sponsor: Pfizer

Sex: All·Age: 18+

Code: NCT07392892·Phase 2, Phase 3·Recruiting·Listed Feb 2026

Apply to this trial

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

for Advanced Non-Small Cell Lung Cancer

186 locations incl. Bullhead City

Sponsor: Pfizer

Sex: All·Age: 18+

Code: NCT07222566·Phase 3·Recruiting·Listed Oct 2025

Apply to this trial

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

for Non-small Cell Carcinoma

133 locations incl. Alabaster

Sponsor: Pfizer

Sex: All·Age: 18+

Code: NCT07144280·Phase 3·Recruiting·Listed Aug 2025

Apply to this trial

A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.

for Breast Cancer

102 locations incl. Chandler

Sponsor: Pfizer

Sex: All·Age: 18+

Code: NCT07062965·Phase 3·Recruiting·Listed Jul 2025

Apply to this trial

MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles

for Breast Cancer

113 locations incl. Anchorage

Sponsor: Agendia

Sex: All·Age: 18+

Code: NCT03053193·Recruiting·Listed Feb 2017

Apply to this trial

More research sites in Bethesda

National Institutes of Health Clinical Center (655 trials)
Walter Reed National Military Medical Center (70 trials)
National Cancer Institute Developmental Therapeutics Clinic (11 trials)
Mid-Atlantic Epilepsy and Sleep Center (8 trials)
National Institutes of Health (8 trials)
National Institute of Health (6 trials)
National Cancer Institute (5 trials)
The Center for Cancer and Blood Disorders (5 trials)
Uniformed Services University of the Health Sciences (5 trials)
American Oncology Partners of Maryland, PA (4 trials)

Explore more

Paid clinical trials in Bethesda, MD · Maryland clinical trials